Literature DB >> 11131159

Uptake and release effects of diethylpropion and its metabolites with biogenic amine transporters.

H Yu1, R B Rothman, C M Dersch, J S Partilla, K C Rice.   

Abstract

Three metabolites of diethylpropion (1), (+/-)-2-ethylamino-1-phenyl-propan-1-one (2), (1R,2S)-(-)-N,N-diethylnorephedrine (3a) and (1S,2R)-(-)-N,N-diethylnorephedrine (3b) were synthesized. Their uptake and release effects with biogenic amine transporters were evaluated. A major finding of this study is that the in vivo activity of diethylpropion on biogenic amine transporters is most likely due to metabolite 2 as diethylpropion (1) and the metabolites 3a and 3b showed little or no effect in the assays studied. These studies also revealed that 2 acted as a substrate at the norepinephrine (IC50 = 99 nM) and serotonin transporters (IC50 = 2118 nM) and an uptake inhibitor at the dopamine transporter (IC50 = 1014 nM). The potent action of 2 at the NE transporter supports the hypothesis that amphetamine-type subjective effects may be mediated in part by brain norepinephrine.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11131159     DOI: 10.1016/s0968-0896(00)00210-8

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  10 in total

1.  Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transporters.

Authors:  Amy J Eshleman; Shanthi Nagarajan; Katherine M Wolfrum; John F Reed; Tracy L Swanson; Aaron Nilsen; Aaron Janowsky
Journal:  Psychopharmacology (Berl)       Date:  2018-11-05       Impact factor: 4.530

Review 2.  Central nervous system biogenic amine targets for control of appetite and energy expenditure.

Authors:  David L Nelson; Donald R Gehlert
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

3.  Hybrid dopamine uptake blocker-serotonin releaser ligands: a new twist on transporter-focused therapeutics.

Authors:  Bruce E Blough; Antonio Landavazo; John S Partilla; Michael H Baumann; Ann M Decker; Kevin M Page; Richard B Rothman
Journal:  ACS Med Chem Lett       Date:  2014-04-15       Impact factor: 4.345

Review 4.  Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter.

Authors:  Maarten E A Reith; Bruce E Blough; Weimin C Hong; Kymry T Jones; Kyle C Schmitt; Michael H Baumann; John S Partilla; Richard B Rothman; Jonathan L Katz
Journal:  Drug Alcohol Depend       Date:  2014-12-18       Impact factor: 4.492

5.  Effects of acute treatment with antidepressant drugs on sensorimotor gating deficits in rats.

Authors:  B Pouzet; M Paabøl Andersen; S Hogg
Journal:  Psychopharmacology (Berl)       Date:  2004-08-27       Impact factor: 4.530

6.  'Second-generation' mephedrone analogs, 4-MEC and 4-MePPP, differentially affect monoamine transporter function.

Authors:  Kusumika Saha; John S Partilla; Kurt R Lehner; Amir Seddik; Thomas Stockner; Marion Holy; Walter Sandtner; Gerhard F Ecker; Harald H Sitte; Michael H Baumann
Journal:  Neuropsychopharmacology       Date:  2014-12-15       Impact factor: 8.294

7.  Phase I metabolites of mephedrone display biological activity as substrates at monoamine transporters.

Authors:  F P Mayer; L Wimmer; O Dillon-Carter; J S Partilla; N V Burchardt; M D Mihovilovic; M H Baumann; H H Sitte
Journal:  Br J Pharmacol       Date:  2016-07-31       Impact factor: 8.739

8.  Receptor and transporter binding and activity profiles of albiflorin extracted from Radix paeoniae Alba.

Authors:  Zeng-Liang Jin; Nana Gao; Weizhe Xu; Pingxiang Xu; Shuaiqi Li; Yuan-Yuan Zheng; Ming Xue
Journal:  Sci Rep       Date:  2016-09-20       Impact factor: 4.379

9.  Spectroscopic characterization and crystal structures of two cathinone derivatives: N-ethyl-2-amino-1-phenylpropan-1-one (ethcathinone) hydrochloride and N-ethyl-2-amino-1-(4-chlorophenyl)propan-1-one (4-CEC) hydrochloride.

Authors:  Piotr Kuś; Joachim Kusz; Maria Książek; Ewelina Pieprzyca; Marcin Rojkiewicz
Journal:  Forensic Toxicol       Date:  2016-10-31       Impact factor: 4.096

Review 10.  Drugs Involved in Dyslipidemia and Obesity Treatment: Focus on Adipose Tissue.

Authors:  Sofia Dias; Sílvia Paredes; Laura Ribeiro
Journal:  Int J Endocrinol       Date:  2018-01-17       Impact factor: 3.257

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.